- Home
- BMRC vs AURA Comparison
BMRC vs AURA Comparison
Compare BMRC & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRC
- AURA
- Stock Information
- Founded
- BMRC 1989
- AURA 2007
- Country
- BMRC United States
- AURA United States
- Employees
- BMRC N/A
- AURA N/A
- Industry
- BMRC Major Banks
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- BMRC Finance
- AURA Health Care
- Exchange
- BMRC Nasdaq
- AURA Nasdaq
- Market Cap
- BMRC 394.5M
- AURA 370.1M
- IPO Year
- BMRC N/A
- AURA 2021
- Fundamental
- Price
- BMRC $19.81
- AURA $5.36
- Analyst Decision
- BMRC Strong Buy
- AURA Strong Buy
- Analyst Count
- BMRC 3
- AURA 4
- Target Price
- BMRC $28.00
- AURA $22.75
- AVG Volume (30 Days)
- BMRC 63.2K
- AURA 411.4K
- Earning Date
- BMRC 04-28-2025
- AURA 05-08-2025
- Dividend Yield
- BMRC 4.89%
- AURA N/A
- EPS Growth
- BMRC N/A
- AURA N/A
- EPS
- BMRC N/A
- AURA N/A
- Revenue
- BMRC $67,983,000.00
- AURA N/A
- Revenue This Year
- BMRC $63.26
- AURA N/A
- Revenue Next Year
- BMRC $9.68
- AURA N/A
- P/E Ratio
- BMRC N/A
- AURA N/A
- Revenue Growth
- BMRC N/A
- AURA N/A
- 52 Week Low
- BMRC $14.11
- AURA $5.51
- 52 Week High
- BMRC $27.11
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- BMRC 22.12
- AURA 30.85
- Support Level
- BMRC $21.51
- AURA $5.53
- Resistance Level
- BMRC $22.50
- AURA $6.24
- Average True Range (ATR)
- BMRC 0.93
- AURA 0.51
- MACD
- BMRC -0.22
- AURA -0.12
- Stochastic Oscillator
- BMRC 4.70
- AURA 12.36
About BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.